RACK1 promotes non-small-cell lung cancer tumorigenicity through activating sonic hedgehog signaling pathway

Shuo Shi1, Yue-Zhen Deng, Jiang-Sha Zhao

  • 1Key Laboratory of Nutrition and Metabolism, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences and Graduate School of Chinese Academy of Sciences, Shanghai 200031, China.

Insights

Receptor of activated kinase 1 (RACK1) is elevated in non-small-cell lung cancer (NSCLC) and promotes tumor growth and metastasis. Silencing RACK1 inhibits tumor progression, suggesting RACK1 as a potential biomarker and therapeutic target for NSCLC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Non-small-cell lung cancer (NSCLC) lacks effective diagnostic biomarkers and therapeutic targets, hindering treatment efficacy.
  • The complete molecular pathogenesis of NSCLC remains incompletely understood, necessitating further investigation into key molecular drivers.

Purpose of the Study:

  • To investigate the role of Receptor of Activated Kinase 1 (RACK1) in the molecular pathogenesis of NSCLC.
  • To evaluate RACK1 as a potential diagnostic biomarker and therapeutic target for NSCLC.

Main Methods:

  • Expression analysis of RACK1 in NSCLC tissues.
  • Correlation analysis between RACK1 expression and pathological characteristics.
  • Investigation of RACK1's interaction with the sonic hedgehog signaling pathway components (Smoothened, Gli1).
  • In vivo studies involving RACK1 silencing to assess tumor growth and metastasis.

Main Results:

  • RACK1 expression was found to be elevated in most NSCLC cases.
  • RACK1 expression levels correlated significantly with tumor differentiation, stage, and metastasis.
  • RACK1 was shown to activate the sonic hedgehog signaling pathway by interacting with Smoothened, leading to Gli1-dependent transcription.
  • Silencing RACK1 significantly inhibited in vivo tumor growth and metastasis by blocking the sonic hedgehog signaling pathway.

Conclusions:

  • RACK1 plays a crucial role in promoting tumor growth and metastasis in NSCLC through the sonic hedgehog signaling pathway.
  • RACK1 represents a promising novel diagnostic biomarker for NSCLC.
  • RACK1 inhibition presents a potential therapeutic strategy for NSCLC treatment.

Related Concept Videos

Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...